Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Disease Management Pilot Program RFP May Be Released By End Of March

This article was originally published in The Pink Sheet Daily

Executive Summary

"Chronic care improvement" program agreements must be signed by Dec. 8 under the Medicare Rx law. Contracted program fees will be at risk. CMS is "setting the bar higher" than what is normally expected from disease management vendors.

You may also be interested in...



Medicare Chronic Care Demo Will Target Physicians To Boost Enrollment

CMS wants to line up a variety of health care providers before beginning to contact beneficiaries. Bulk of promotions will be undertaken by disease management contractors.

Disease Management Pilot Programs For Medicare Will Target 10 Geographic Areas

HHS will prospectively identify at least 30,000 beneficiaries in each area. Applications are due Aug. 6; the programs will begin “this year.”

Medicare Disease Management Demo RFP Expected Week Of April 19

Aetna says it is "very excited" to participate in the chronic care improvement demonstration project.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058913

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel